25 XP   0   0   10

ORIENTBIO Inc.
Buy, Hold or Sell?

Let's analyse Orient together

PenkeI guess you are interested in ORIENTBIO Inc.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of ORIENTBIO Inc.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about ORIENTBIO Inc.

I send you an email if I find something interesting about ORIENTBIO Inc..

Quick analysis of Orient (30 sec.)










What can you expect buying and holding a share of Orient? (30 sec.)

How much money do you get?

How much money do you get?
₩0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
₩619.89
Expected worth in 1 year
₩645.97
How sure are you?
48.7%

+ What do you gain per year?

Total Gains per Share
₩26.08
Return On Investment
4.4%

For what price can you sell your share?

Current Price per Share
₩598.00
Expected price per share
₩555.00 - ₩632.00
How sure are you?
50%

1. Valuation of Orient (5 min.)




Live pricePrice per Share (EOD)

₩598.00

Intrinsic Value Per Share

₩749.78 - ₩887.13

Total Value Per Share

₩1,369.67 - ₩1,507.03

2. Growth of Orient (5 min.)




Is Orient growing?

Current yearPrevious yearGrowGrow %
How rich?$51.4m$53.1m-$1.9m-3.9%

How much money is Orient making?

Current yearPrevious yearGrowGrow %
Making money$418.5k-$3m$3.4m821.2%
Net Profit Margin8.5%-57.6%--

How much money comes from the company's main activities?

3. Financial Health of Orient (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#474 / 1031

Most Revenue
#357 / 1031

Most Profit
#151 / 1031

Most Efficient
#132 / 1031

What can you expect buying and holding a share of Orient? (5 min.)

Welcome investor! Orient's management wants to use your money to grow the business. In return you get a share of Orient.

What can you expect buying and holding a share of Orient?

First you should know what it really means to hold a share of Orient. And how you can make/lose money.

Speculation

The Price per Share of Orient is ₩598.00. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Orient.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Orient, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₩619.89. Based on the TTM, the Book Value Change Per Share is ₩6.52 per quarter. Based on the YOY, the Book Value Change Per Share is ₩49.43 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₩0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Orient.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.000.0%0.000.0%-0.030.0%-0.010.0%-0.010.0%
Usd Book Value Change Per Share0.000.0%0.000.0%0.030.0%-0.010.0%0.000.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.000.0%0.000.0%0.030.0%-0.010.0%0.000.0%
Usd Price Per Share0.42-0.46-0.46-0.59-0.69-
Price to Earnings Ratio84.35-24.69--0.59--7.13--3.29-
Price-to-Total Gains Ratio390.64-97.28-2.21-309.26-123.05-
Price to Book Ratio0.98-1.06-1.02-1.72-1.60-
Price-to-Total Gains Ratio390.64-97.28-2.21-309.26-123.05-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.4186
Number of shares2388
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.00-0.01
Usd Total Gains Per Share0.00-0.01
Gains per Quarter (2388 shares)10.90-19.17
Gains per Year (2388 shares)43.59-76.68
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1044340-77-87
2087780-153-164
301311220-230-241
401741660-307-318
502182100-383-395
602622540-460-472
703052980-537-549
803493420-613-626
903923860-690-703
1004364300-767-780

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share3.01.00.075.0%6.05.00.054.5%7.012.00.036.8%10.020.09.025.6%10.020.012.023.8%
Book Value Change Per Share3.01.00.075.0%8.03.00.072.7%11.08.00.057.9%19.020.00.048.7%21.021.00.050.0%
Dividend per Share0.00.04.00.0%0.00.011.00.0%0.00.019.00.0%0.00.039.00.0%0.00.042.00.0%
Total Gains per Share3.01.00.075.0%8.03.00.072.7%11.08.00.057.9%19.020.00.048.7%21.021.00.050.0%

Fundamentals of Orient

About ORIENTBIO Inc.

ORIENT BIO Inc. operates in the bio-industry in South Korea. It produces laboratory animals; and offers various equipment for research environment. The company was formerly known as Orient Co., Ltd. and changed its name to ORIENT BIO Inc. in 2005. ORIENT BIO Inc. was founded in 1959 and is based in Seongnam-si, South Korea.

Fundamental data was last updated by Penke on 2024-03-24 04:06:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of ORIENTBIO Inc..

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Orient earns for each ₩1 of revenue.

  • Above 10% is considered healthy but always compare Orient to the Biotechnology industry mean.
  • A Net Profit Margin of 2.6% means that ₩0.03 for each ₩1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of ORIENTBIO Inc.:

  • The MRQ is 2.6%. The company is making a profit. +1
  • The TTM is 8.5%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ2.6%TTM8.5%-5.9%
TTM8.5%YOY-57.6%+66.1%
TTM8.5%5Y-19.8%+28.3%
5Y-19.8%10Y-12.4%-7.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.6%-159.2%+161.8%
TTM8.5%-202.3%+210.8%
YOY-57.6%-263.0%+205.4%
5Y-19.8%-452.4%+432.6%
10Y-12.4%-589.0%+576.6%
1.1.2. Return on Assets

Shows how efficient Orient is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Orient to the Biotechnology industry mean.
  • 0.3% Return on Assets means that Orient generated ₩0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of ORIENTBIO Inc.:

  • The MRQ is 0.3%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.7%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.3%TTM0.7%-0.5%
TTM0.7%YOY-5.4%+6.2%
TTM0.7%5Y-3.0%+3.7%
5Y-3.0%10Y-1.9%-1.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3%-12.5%+12.8%
TTM0.7%-12.2%+12.9%
YOY-5.4%-11.2%+5.8%
5Y-3.0%-13.3%+10.3%
10Y-1.9%-14.6%+12.7%
1.1.3. Return on Equity

Shows how efficient Orient is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Orient to the Biotechnology industry mean.
  • 0.3% Return on Equity means Orient generated ₩0.00 for each ₩1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of ORIENTBIO Inc.:

  • The MRQ is 0.3%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 0.8%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.3%TTM0.8%-0.5%
TTM0.8%YOY-6.5%+7.3%
TTM0.8%5Y-4.0%+4.8%
5Y-4.0%10Y-3.4%-0.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3%-16.0%+16.3%
TTM0.8%-15.8%+16.6%
YOY-6.5%-13.9%+7.4%
5Y-4.0%-18.2%+14.2%
10Y-3.4%-19.1%+15.7%

1.2. Operating Efficiency of ORIENTBIO Inc..

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Orient is operating .

  • Measures how much profit Orient makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Orient to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated ₩0.00  for each ₩1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of ORIENTBIO Inc.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-5.6%+5.6%
5Y-5.6%10Y-4.2%-1.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--299.5%+299.5%
TTM--208.5%+208.5%
YOY--280.2%+280.2%
5Y-5.6%-459.9%+454.3%
10Y-4.2%-596.9%+592.7%
1.2.2. Operating Ratio

Measures how efficient Orient is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.68 means that the operating costs are ₩1.68 for each ₩1 in net sales.

Let's take a look of the Operating Ratio trends of ORIENTBIO Inc.:

  • The MRQ is 1.684. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.595. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.684TTM1.595+0.089
TTM1.595YOY1.563+0.032
TTM1.5955Y1.535+0.059
5Y1.53510Y1.420+0.116
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6842.817-1.133
TTM1.5953.181-1.586
YOY1.5633.609-2.046
5Y1.5355.554-4.019
10Y1.4207.396-5.976

1.3. Liquidity of ORIENTBIO Inc..

1.3. Liquidity
1.3.1. Current Ratio

Measures if Orient is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 16.65 means the company has ₩16.65 in assets for each ₩1 in short-term debts.

Let's take a look of the Current Ratio trends of ORIENTBIO Inc.:

  • The MRQ is 16.649. The company is very able to pay all its short-term debts. +2
  • The TTM is 16.167. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ16.649TTM16.167+0.482
TTM16.167YOY9.552+6.615
TTM16.1675Y6.201+9.965
5Y6.20110Y3.656+2.545
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ16.6493.987+12.662
TTM16.1674.440+11.727
YOY9.5525.569+3.983
5Y6.2016.158+0.043
10Y3.6566.492-2.836
1.3.2. Quick Ratio

Measures if Orient is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Orient to the Biotechnology industry mean.
  • A Quick Ratio of 9.83 means the company can pay off ₩9.83 for each ₩1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of ORIENTBIO Inc.:

  • The MRQ is 9.834. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 10.245. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ9.834TTM10.245-0.411
TTM10.245YOY12.817-2.572
TTM10.2455Y5.011+5.234
5Y5.01110Y2.793+2.218
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ9.8343.653+6.181
TTM10.2454.158+6.087
YOY12.8175.515+7.302
5Y5.0116.012-1.001
10Y2.7936.206-3.413

1.4. Solvency of ORIENTBIO Inc..

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Orient assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Orient to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.12 means that Orient assets are financed with 11.7% credit (debt) and the remaining percentage (100% - 11.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of ORIENTBIO Inc.:

  • The MRQ is 0.117. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.114. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.117TTM0.114+0.004
TTM0.114YOY0.153-0.040
TTM0.1145Y0.228-0.115
5Y0.22810Y0.367-0.138
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1170.336-0.219
TTM0.1140.330-0.216
YOY0.1530.267-0.114
5Y0.2280.367-0.139
10Y0.3670.378-0.011
1.4.2. Debt to Equity Ratio

Measures if Orient is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Orient to the Biotechnology industry mean.
  • A Debt to Equity ratio of 13.3% means that company has ₩0.13 debt for each ₩1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of ORIENTBIO Inc.:

  • The MRQ is 0.133. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.128. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.133TTM0.128+0.005
TTM0.128YOY0.182-0.054
TTM0.1285Y0.308-0.180
5Y0.30810Y0.875-0.566
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1330.376-0.243
TTM0.1280.398-0.270
YOY0.1820.334-0.152
5Y0.3080.431-0.123
10Y0.8750.476+0.399

2. Market Valuation of ORIENTBIO Inc.

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₩1 in earnings Orient generates.

  • Above 15 is considered overpriced but always compare Orient to the Biotechnology industry mean.
  • A PE ratio of 84.35 means the investor is paying ₩84.35 for every ₩1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of ORIENTBIO Inc.:

  • The EOD is 83.099. Based on the earnings, the company is expensive. -2
  • The MRQ is 84.350. Based on the earnings, the company is expensive. -2
  • The TTM is 24.686. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD83.099MRQ84.350-1.251
MRQ84.350TTM24.686+59.664
TTM24.686YOY-0.595+25.280
TTM24.6865Y-7.127+31.812
5Y-7.12710Y-3.290-3.837
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD83.099-2.697+85.796
MRQ84.350-2.422+86.772
TTM24.686-2.709+27.395
YOY-0.595-4.116+3.521
5Y-7.127-6.257-0.870
10Y-3.290-6.478+3.188
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of ORIENTBIO Inc.:

  • The EOD is 10.240. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 10.394. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 6.389. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD10.240MRQ10.394-0.154
MRQ10.394TTM6.389+4.005
TTM6.389YOY14.961-8.572
TTM6.3895Y8.948-2.559
5Y8.94810Y-1.711+10.659
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD10.240-3.344+13.584
MRQ10.394-2.939+13.333
TTM6.389-3.486+9.875
YOY14.961-5.592+20.553
5Y8.948-8.464+17.412
10Y-1.711-8.872+7.161
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Orient is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.98 means the investor is paying ₩0.98 for each ₩1 in book value.

Let's take a look of the Price to Book Ratio trends of ORIENTBIO Inc.:

  • The EOD is 0.965. Based on the equity, the company is cheap. +2
  • The MRQ is 0.979. Based on the equity, the company is cheap. +2
  • The TTM is 1.058. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.965MRQ0.979-0.015
MRQ0.979TTM1.058-0.078
TTM1.058YOY1.024+0.033
TTM1.0585Y1.723-0.666
5Y1.72310Y1.602+0.122
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.9652.198-1.233
MRQ0.9792.042-1.063
TTM1.0582.121-1.063
YOY1.0242.907-1.883
5Y1.7233.682-1.959
10Y1.6024.114-2.512
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of ORIENTBIO Inc. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--1.5546.519-76%49.434-97%-11.468+838%1.240+25%
Book Value Per Share--619.893616.226+1%640.135-3%522.706+19%633.122-2%
Current Ratio--16.64916.167+3%9.552+74%6.201+168%3.656+355%
Debt To Asset Ratio--0.1170.114+3%0.153-24%0.228-49%0.367-68%
Debt To Equity Ratio--0.1330.128+4%0.182-27%0.308-57%0.875-85%
Dividend Per Share----0%-0%-0%-0%
Eps--1.7995.042-64%-36.365+2121%-15.334+952%-14.473+904%
Free Cash Flow Per Share--14.6006.325+131%-0.706+105%-1.425+110%-12.696+187%
Free Cash Flow To Equity Per Share--14.6006.325+131%-0.706+105%-4.138+128%25.937-44%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.769+30%
Intrinsic Value_10Y_max--887.132--------
Intrinsic Value_10Y_min--749.781--------
Intrinsic Value_1Y_max--44.611--------
Intrinsic Value_1Y_min--43.793--------
Intrinsic Value_3Y_max--167.789--------
Intrinsic Value_3Y_min--159.504--------
Intrinsic Value_5Y_max--331.659--------
Intrinsic Value_5Y_min--304.932--------
Market Cap70903664000.000-2%71970852482.00077306418152.000-7%77306418152.000-7%100345030999.284-28%117390946110.605-39%
Net Profit Margin--0.0260.085-69%-0.576+2310%-0.198+861%-0.124+575%
Operating Margin----0%-0%-0.0560%-0.0420%
Operating Ratio--1.6841.595+6%1.563+8%1.535+10%1.420+19%
Pb Ratio0.965-2%0.9791.058-7%1.024-4%1.723-43%1.602-39%
Pe Ratio83.099-2%84.35024.686+242%-0.595+101%-7.127+108%-3.290+104%
Price Per Share598.000-2%607.000652.000-7%652.000-7%846.307-28%990.073-39%
Price To Free Cash Flow Ratio10.240-2%10.3946.389+63%14.961-31%8.948+16%-1.711+116%
Price To Total Gains Ratio384.849-2%390.64197.276+302%2.209+17584%309.261+26%123.054+217%
Quick Ratio--9.83410.245-4%12.817-23%5.011+96%2.793+252%
Return On Assets--0.0030.007-65%-0.054+2223%-0.030+1264%-0.019+841%
Return On Equity--0.0030.008-64%-0.065+2348%-0.040+1481%-0.034+1264%
Total Gains Per Share--1.5546.519-76%49.434-97%-11.468+838%1.240+25%
Usd Book Value--51449684.70651145311.347+1%53129686.776-3%43383392.604+19%52547628.197-2%
Usd Book Value Change Per Share--0.0010.005-76%0.035-97%-0.008+838%0.001+25%
Usd Book Value Per Share--0.4340.431+1%0.448-3%0.366+19%0.443-2%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.0010.004-64%-0.025+2121%-0.011+952%-0.010+904%
Usd Free Cash Flow--1211776.643524935.808+131%-58631.629+105%-118249.103+110%-837586.029+169%
Usd Free Cash Flow Per Share--0.0100.004+131%0.000+105%-0.001+110%-0.009+187%
Usd Free Cash Flow To Equity Per Share--0.0100.004+131%0.000+105%-0.003+128%0.018-44%
Usd Market Cap49632564.800-2%50379596.73754114492.706-7%54114492.706-7%70241521.699-28%82173662.277-39%
Usd Price Per Share0.419-2%0.4250.456-7%0.456-7%0.592-28%0.693-39%
Usd Profit--149317.357418499.548-64%-3018226.806+2121%-1626187.136+1189%-1373434.729+1020%
Usd Revenue--5728921.2194825918.799+19%5333763.199+7%9354744.106-39%14468875.725-60%
Usd Total Gains Per Share--0.0010.005-76%0.035-97%-0.008+838%0.001+25%
 EOD+4 -4MRQTTM+13 -19YOY+19 -135Y+25 -710Y+21 -12

3.2. Fundamental Score

Let's check the fundamental score of ORIENTBIO Inc. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1583.099
Price to Book Ratio (EOD)Between0-10.965
Net Profit Margin (MRQ)Greater than00.026
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than19.834
Current Ratio (MRQ)Greater than116.649
Debt to Asset Ratio (MRQ)Less than10.117
Debt to Equity Ratio (MRQ)Less than10.133
Return on Equity (MRQ)Greater than0.150.003
Return on Assets (MRQ)Greater than0.050.003
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of ORIENTBIO Inc. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5062.722
Ma 20Greater thanMa 50575.700
Ma 50Greater thanMa 100583.700
Ma 100Greater thanMa 200595.330
OpenGreater thanClose589.000
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in KRW. All numbers in thousands.

Summary
Total Assets83,254,491
Total Liabilities9,754,941
Total Stockholder Equity73,499,549
 As reported
Total Liabilities 9,754,941
Total Stockholder Equity+ 73,499,549
Total Assets = 83,254,491

Assets

Total Assets83,254,491
Total Current Assets57,971,236
Long-term Assets25,283,255
Total Current Assets
Cash And Cash Equivalents 5,535,651
Short-term Investments 28,653,360
Net Receivables 5,590,339
Inventory 5,579,369
Total Current Assets  (as reported)57,971,236
Total Current Assets  (calculated)45,358,720
+/- 12,612,516
Long-term Assets
Property Plant Equipment 14,172,396
Goodwill 1
Intangible Assets 272,561
Long-term Assets  (as reported)25,283,255
Long-term Assets  (calculated)14,444,958
+/- 10,838,297

Liabilities & Shareholders' Equity

Total Current Liabilities3,482,065
Long-term Liabilities6,272,876
Total Stockholder Equity73,499,549
Total Current Liabilities
Accounts payable 695,679
Other Current Liabilities -1
Total Current Liabilities  (as reported)3,482,065
Total Current Liabilities  (calculated)695,678
+/- 2,786,387
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt531,045
Long-term Liabilities  (as reported)6,272,876
Long-term Liabilities  (calculated)531,045
+/- 5,741,830
Total Stockholder Equity
Retained Earnings 4,351,607
Total Stockholder Equity (as reported)73,499,549
Total Stockholder Equity (calculated)4,351,607
+/- 69,147,942
Other
Capital Stock59,291,503
Common Stock Shares Outstanding 118,568
Net Invested Capital 73,499,549
Net Working Capital 54,489,170
Property Plant and Equipment Gross 63,491,843



Balance Sheet

Currency in KRW. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312011-12-312011-09-302011-06-302010-12-312010-09-302010-06-302009-12-312009-09-302009-06-302008-12-312008-09-302008-06-302007-12-312007-09-302007-06-30
> Total Assets 
179,767,766
59,418,238
62,003,621
82,507,020
73,591,342
86,149,831
86,033,279
83,870,204
80,223,706
82,895,759
81,691,106
68,950,065
61,070,051
56,058,719
55,327,662
136,244,515
136,493,872
146,507,086
144,483,603
139,630,721
137,970,840
143,045,446
146,457,962
148,764,894
177,702,546
170,786,784
179,596,862
175,642,243
192,464,680
186,067,273
179,104,245
172,626,053
193,366,017
195,251,450
185,042,084
190,030,913
176,714,287
195,635,943
186,589,520
84,088,996
82,677,634
75,384,942
71,779,804
72,105,395
74,054,780
82,895,271
81,247,856
71,046,883
71,943,674
71,916,980
82,129,888
92,126,500
95,992,383
80,981,415
81,050,220
83,039,107
82,327,212
83,254,491
83,254,49182,327,21283,039,10781,050,22080,981,41595,992,38392,126,50082,129,88871,916,98071,943,67471,046,88381,247,85682,895,27174,054,78072,105,39571,779,80475,384,94282,677,63484,088,996186,589,520195,635,943176,714,287190,030,913185,042,084195,251,450193,366,017172,626,053179,104,245186,067,273192,464,680175,642,243179,596,862170,786,784177,702,546148,764,894146,457,962143,045,446137,970,840139,630,721144,483,603146,507,086136,493,872136,244,51555,327,66256,058,71961,070,05168,950,06581,691,10682,895,75980,223,70683,870,20486,033,27986,149,83173,591,34282,507,02062,003,62159,418,238179,767,766
   > Total Current Assets 
11,463,553
11,373,442
13,514,819
29,889,876
20,095,811
30,296,115
29,211,806
23,022,711
19,228,775
21,672,234
20,335,074
23,376,755
17,218,144
20,056,248
18,320,197
68,077,023
65,331,062
72,371,100
68,268,883
62,603,862
60,792,979
62,219,526
61,663,632
65,163,447
95,119,674
86,711,919
84,437,120
71,908,700
90,193,400
85,233,517
84,893,291
77,333,367
97,692,644
86,928,437
82,101,877
95,865,336
79,302,663
95,005,441
82,567,820
32,335,812
30,678,486
27,911,300
20,260,804
22,179,284
25,477,515
27,854,372
27,917,162
28,588,865
30,376,398
29,144,342
39,833,724
58,832,263
66,619,329
52,873,726
49,249,572
54,101,704
56,714,388
57,971,236
57,971,23656,714,38854,101,70449,249,57252,873,72666,619,32958,832,26339,833,72429,144,34230,376,39828,588,86527,917,16227,854,37225,477,51522,179,28420,260,80427,911,30030,678,48632,335,81282,567,82095,005,44179,302,66395,865,33682,101,87786,928,43797,692,64477,333,36784,893,29185,233,51790,193,40071,908,70084,437,12086,711,91995,119,67465,163,44761,663,63262,219,52660,792,97962,603,86268,268,88372,371,10065,331,06268,077,02318,320,19720,056,24817,218,14423,376,75520,335,07421,672,23419,228,77523,022,71129,211,80630,296,11520,095,81129,889,87613,514,81911,373,44211,463,553
       Cash And Cash Equivalents 
936,351
221,700
1,570,734
579,554
620,640
9,824,080
7,211,878
9,343,175
1,434,573
1,433,565
244,354
5,027,408
748,878
749,717
392,850
1,954,348
1,715,762
8,873,448
4,551,927
1,128,631
1,213,002
4,271,195
2,198,812
1,249,040
27,583,432
13,881,805
15,904,144
8,439,143
25,020,724
17,803,303
24,381,467
19,009,956
39,394,195
27,993,435
21,628,747
24,438,287
10,530,106
31,278,485
11,909,870
9,169,895
5,400,425
8,270,719
4,265,016
2,349,782
3,036,912
7,379,249
5,661,838
10,940,023
7,654,716
4,574,764
11,601,876
23,133,107
6,028,459
5,282,958
5,934,227
5,717,617
2,717,166
5,535,651
5,535,6512,717,1665,717,6175,934,2275,282,9586,028,45923,133,10711,601,8764,574,7647,654,71610,940,0235,661,8387,379,2493,036,9122,349,7824,265,0168,270,7195,400,4259,169,89511,909,87031,278,48510,530,10624,438,28721,628,74727,993,43539,394,19519,009,95624,381,46717,803,30325,020,7248,439,14315,904,14413,881,80527,583,4321,249,0402,198,8124,271,1951,213,0021,128,6314,551,9278,873,4481,715,7621,954,348392,850749,717748,8785,027,408244,3541,433,5651,434,5739,343,1757,211,8789,824,080620,640579,5541,570,734221,700936,351
       Short-term Investments 
3,737,823
3,737,823
3,737,823
19,767,186
8,169,496
8,309,723
8,035,300
50,300
2,990,300
3,439,100
3,489,100
3,489,100
2,263,598
3,058,218
2,372,269
12,391,980
12,754,539
13,359,085
12,363,552
11,584,151
9,712,259
5,651,694
6,066,500
6,191,512
6,174,024
5,226,574
903,027
1,273,027
1,376,027
3,075,027
1,625,227
2,023,773
2,262,773
2,891,773
2,494,589
12,622,600
2,362,825
2,294,116
8,542,951
901,532
1,690,932
2,380,643
1,606,920
801,000
800,000
800,000
2,657,233
800,001
800,000
800,000
799,999
21,717,263
42,028,245
29,591,595
29,532,079
29,956,580
28,689,478
28,653,360
28,653,36028,689,47829,956,58029,532,07929,591,59542,028,24521,717,263799,999800,000800,000800,0012,657,233800,000800,000801,0001,606,9202,380,6431,690,932901,5328,542,9512,294,1162,362,82512,622,6002,494,5892,891,7732,262,7732,023,7731,625,2273,075,0271,376,0271,273,027903,0275,226,5746,174,0246,191,5126,066,5005,651,6949,712,25911,584,15112,363,55213,359,08512,754,53912,391,9802,372,2693,058,2182,263,5983,489,1003,489,1003,439,1002,990,30050,3008,035,3008,309,7238,169,49619,767,1863,737,8233,737,8233,737,823
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
18,235,815
16,006,661
15,549,494
19,071,527
16,906,332
17,851,689
19,114,070
18,986,521
18,871,179
19,462,359
17,975,746
18,089,053
17,794,478
18,124,179
18,584,020
17,714,129
17,259,379
16,377,123
17,659,600
23,338,952
22,161,591
20,518,066
29,000,319
6,720,640
5,765,341
4,417,478
5,439,263
9,336,984
10,631,405
8,677,423
11,032,474
9,416,235
12,586,528
13,010,745
13,672,957
5,074,519
5,708,727
5,102,066
4,870,790
4,928,045
6,340,080
5,590,339
5,590,3396,340,0804,928,0454,870,7905,102,0665,708,7275,074,51913,672,95713,010,74512,586,5289,416,23511,032,4748,677,42310,631,4059,336,9845,439,2634,417,4785,765,3416,720,64029,000,31920,518,06622,161,59123,338,95217,659,60016,377,12317,259,37917,714,12918,584,02018,124,17917,794,47818,089,05317,975,74619,462,35918,871,17918,986,52119,114,07017,851,68916,906,33219,071,52715,549,49416,006,66118,235,8150000000000000000
       Inventory 
2,758,621
3,074,023
3,211,536
4,144,575
4,849,675
5,172,101
6,150,625
6,708,408
6,845,934
7,514,733
7,034,119
6,417,659
1,029,231
7,026,360
7,289,571
23,521,629
23,753,439
25,450,936
26,368,962
25,669,374
26,809,737
27,835,881
28,000,831
30,139,205
31,840,395
32,879,470
31,734,695
32,503,892
33,922,352
34,309,736
28,986,141
28,633,566
28,273,975
29,006,202
31,043,371
31,255,249
33,592,352
33,694,010
28,874,430
10,011,174
11,376,674
8,192,608
8,860,461
8,102,411
7,051,043
7,741,530
6,791,119
5,927,585
7,353,304
8,351,923
7,500,393
5,509,875
5,270,747
5,415,130
5,244,567
5,654,199
5,631,625
5,579,369
5,579,3695,631,6255,654,1995,244,5675,415,1305,270,7475,509,8757,500,3938,351,9237,353,3045,927,5856,791,1197,741,5307,051,0438,102,4118,860,4618,192,60811,376,67410,011,17428,874,43033,694,01033,592,35231,255,24931,043,37129,006,20228,273,97528,633,56628,986,14134,309,73633,922,35232,503,89231,734,69532,879,47031,840,39530,139,20528,000,83127,835,88126,809,73725,669,37426,368,96225,450,93623,753,43923,521,6297,289,5717,026,3601,029,2316,417,6597,034,1197,514,7336,845,9346,708,4086,150,6255,172,1014,849,6754,144,5753,211,5363,074,0232,758,621
       Other Current Assets 
4,030,758
4,339,896
4,994,726
5,398,561
6,456,000
6,990,211
7,814,003
6,920,828
7,957,968
9,284,836
9,567,501
8,442,588
13,176,437
9,221,953
8,265,507
30,209,066
27,107,322
24,687,631
24,984,442
24,221,707
23,057,981
24,460,756
25,397,489
27,583,689
29,521,823
34,724,070
35,895,254
29,692,638
29,874,297
30,045,451
29,900,456
27,666,071
27,761,701
27,037,027
26,935,170
27,549,199
32,817,380
27,738,830
33,240,569
12,253,211
12,210,455
9,067,330
5,528,407
10,926,091
14,589,559
11,933,593
12,806,973
10,921,256
14,568,378
15,417,655
19,931,455
-687,187
-706,387
-932,652
-950,289
-6,106,184
-1
-1
-1-1-6,106,184-950,289-932,652-706,387-687,18719,931,45515,417,65514,568,37810,921,25612,806,97311,933,59314,589,55910,926,0915,528,4079,067,33012,210,45512,253,21133,240,56927,738,83032,817,38027,549,19926,935,17027,037,02727,761,70127,666,07129,900,45630,045,45129,874,29729,692,63835,895,25434,724,07029,521,82327,583,68925,397,48924,460,75623,057,98124,221,70724,984,44224,687,63127,107,32230,209,0668,265,5079,221,95313,176,4378,442,5889,567,5019,284,8367,957,9686,920,8287,814,0036,990,2116,456,0005,398,5614,994,7264,339,8964,030,758
   > Long-term Assets 
168,304,213
48,044,796
48,488,802
52,617,144
53,495,531
55,853,716
56,821,473
60,847,493
60,994,931
61,223,525
61,356,032
45,573,310
43,851,907
36,002,471
37,007,465
68,167,491
71,162,810
74,135,986
76,214,720
77,026,858
77,177,861
80,825,920
84,794,330
83,601,448
82,582,872
84,074,865
95,159,742
103,733,542
102,271,280
100,833,756
94,210,954
95,292,686
95,673,373
108,323,013
102,940,207
94,165,577
97,411,624
100,630,502
104,021,700
51,753,185
51,999,148
47,473,642
51,519,000
49,926,111
48,577,266
55,040,900
53,330,694
42,458,018
41,567,276
42,772,638
42,296,164
33,294,237
29,373,054
28,107,689
31,800,648
28,937,403
25,612,824
25,283,255
25,283,25525,612,82428,937,40331,800,64828,107,68929,373,05433,294,23742,296,16442,772,63841,567,27642,458,01853,330,69455,040,90048,577,26649,926,11151,519,00047,473,64251,999,14851,753,185104,021,700100,630,50297,411,62494,165,577102,940,207108,323,01395,673,37395,292,68694,210,954100,833,756102,271,280103,733,54295,159,74284,074,86582,582,87283,601,44884,794,33080,825,92077,177,86177,026,85876,214,72074,135,98671,162,81068,167,49137,007,46536,002,47143,851,90745,573,31061,356,03261,223,52560,994,93160,847,49356,821,47355,853,71653,495,53152,617,14448,488,80248,044,796168,304,213
       Property Plant Equipment 
33,867,025
33,362,455
32,881,206
32,709,877
33,357,328
34,690,687
35,872,098
35,121,037
34,308,061
33,418,717
33,075,678
16,797,258
16,750,918
16,404,180
16,262,985
34,407,327
37,485,684
40,417,886
42,219,169
45,516,199
44,989,094
44,186,935
45,889,825
46,809,822
46,051,748
45,514,671
49,407,769
57,154,174
54,165,220
53,800,185
53,451,880
54,852,951
53,522,822
65,443,533
63,484,300
61,910,904
61,321,475
65,218,830
64,946,668
41,668,860
41,203,428
39,288,271
38,107,340
37,777,546
36,655,878
37,251,758
34,808,571
31,321,039
30,342,253
31,551,320
30,935,803
17,667,363
16,953,815
16,543,128
15,856,583
14,791,596
14,169,665
14,172,396
14,172,39614,169,66514,791,59615,856,58316,543,12816,953,81517,667,36330,935,80331,551,32030,342,25331,321,03934,808,57137,251,75836,655,87837,777,54638,107,34039,288,27141,203,42841,668,86064,946,66865,218,83061,321,47561,910,90463,484,30065,443,53353,522,82254,852,95153,451,88053,800,18554,165,22057,154,17449,407,76945,514,67146,051,74846,809,82245,889,82544,186,93544,989,09445,516,19942,219,16940,417,88637,485,68434,407,32716,262,98516,404,18016,750,91816,797,25833,075,67833,418,71734,308,06135,121,03735,872,09834,690,68733,357,32832,709,87732,881,20633,362,45533,867,025
       Goodwill 
1
1
1
1
1
1
1
1
1
1
1
1
1
1
0
4,004,783
4,004,783
4,004,783
4,004,783
4,004,783
4,004,783
4,004,783
5,619,351
5,894,171
5,894,171
5,894,171
13,761,999
13,761,999
13,761,999
13,761,999
10,077,238
10,077,238
10,077,238
10,638,657
7,988,251
7,988,251
7,988,251
7,988,251
5,894,171
1
1
1
1
1
1
1
1
1
0
0
0
1
1
1
1
1
1
1
11111110001111111115,894,1717,988,2517,988,2517,988,2517,988,25110,638,65710,077,23810,077,23810,077,23813,761,99913,761,99913,761,99913,761,9995,894,1715,894,1715,894,1715,619,3514,004,7834,004,7834,004,7834,004,7834,004,7834,004,7834,004,783011111111111111
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
824,097
795,680
908,483
968,487
1,028,493
1,087,003
1,142,008
1,079,477
11,154,482
5,803,908
5,886,866
1,665,476
1,827,843
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000001,827,8431,665,4765,886,8665,803,90811,154,4821,079,4771,142,0081,087,0031,028,493968,487908,483795,680824,097000000000000000000000000000000
       Intangible Assets 
924,806
1,246,897
1,621,834
2,713,414
3,234,049
3,709,281
3,966,448
4,838,594
5,799,728
6,828,861
7,145,296
7,443,434
8,055,703
8,138,004
8,271,224
11,153,237
11,362,164
11,333,312
11,591,591
9,135,777
9,867,964
9,836,087
10,198,082
10,805,404
10,740,679
11,290,859
11,281,121
11,793,624
12,405,180
12,718,282
10,463,507
10,182,417
10,619,283
10,502,203
10,181,937
2,629,611
2,488,075
2,346,539
4,555,004
2,646,702
2,535,140
2,407,916
2,288,549
2,208,932
2,089,045
1,968,399
1,848,131
474,531
471,764
469,646
467,850
476,389
474,281
475,583
276,995
277,188
274,836
272,561
272,561274,836277,188276,995475,583474,281476,389467,850469,646471,764474,5311,848,1311,968,3992,089,0452,208,9322,288,5492,407,9162,535,1402,646,7024,555,0042,346,5392,488,0752,629,61110,181,93710,502,20310,619,28310,182,41710,463,50712,718,28212,405,18011,793,62411,281,12111,290,85910,740,67910,805,40410,198,0829,836,0879,867,9649,135,77711,591,59111,333,31211,362,16411,153,2378,271,2248,138,0048,055,7037,443,4347,145,2966,828,8615,799,7284,838,5943,966,4483,709,2813,234,0492,713,4141,621,8341,246,897924,806
       Long-term Assets Other 
4,106,333
4,104,912
4,105,682
22,155,046
10,533,756
10,745,982
10,468,160
2,473,260
5,413,259
5,922,060
5,972,060
6,107,259
4,417,757
3,612,378
2,921,429
28,503,347
28,701,341
29,265,760
28,234,329
27,395,846
25,489,868
21,411,509
22,439,629
22,260,856
21,891,586
20,916,121
16,569,354
16,837,793
16,854,224
18,526,427
17,050,364
17,513,723
17,757,771
18,635,931
18,189,303
28,290,900
17,714,682
17,560,821
23,785,561
1,823,712
2,613,111
3,300,322
2,526,599
8,982,127
8,903,599
8,332,311
3,563,123
3,762,050
3,749,307
3,762,049
3,764,232
29,313,570
45,244,860
32,808,211
0
-1
0
0
00-1032,808,21145,244,86029,313,5703,764,2323,762,0493,749,3073,762,0503,563,1238,332,3118,903,5998,982,1272,526,5993,300,3222,613,1111,823,71223,785,56117,560,82117,714,68228,290,90018,189,30318,635,93117,757,77117,513,72317,050,36418,526,42716,854,22416,837,79316,569,35420,916,12121,891,58622,260,85622,439,62921,411,50925,489,86827,395,84628,234,32929,265,76028,701,34128,503,3472,921,4293,612,3784,417,7576,107,2595,972,0605,922,0605,413,2592,473,26010,468,16010,745,98210,533,75622,155,0464,105,6824,104,9124,106,333
> Total Liabilities 
136,686,605
25,228,277
27,364,591
26,482,941
17,449,483
29,995,457
30,779,967
26,283,965
23,810,333
26,842,714
26,679,885
6,276,746
8,211,192
13,626,233
12,691,495
73,954,972
75,193,644
77,839,172
76,715,946
77,784,689
76,279,653
75,313,594
77,705,521
81,415,072
84,995,341
78,831,563
85,741,557
84,352,075
88,460,483
83,086,582
79,006,029
74,681,088
92,799,306
99,960,499
95,417,992
110,107,436
93,162,697
96,030,742
87,254,499
21,442,606
20,337,955
20,707,607
17,167,365
20,142,435
21,820,721
28,463,821
23,691,875
21,438,455
19,609,369
19,552,259
29,305,987
17,799,760
13,028,232
10,573,649
9,657,862
8,987,405
9,011,900
9,754,941
9,754,9419,011,9008,987,4059,657,86210,573,64913,028,23217,799,76029,305,98719,552,25919,609,36921,438,45523,691,87528,463,82121,820,72120,142,43517,167,36520,707,60720,337,95521,442,60687,254,49996,030,74293,162,697110,107,43695,417,99299,960,49992,799,30674,681,08879,006,02983,086,58288,460,48384,352,07585,741,55778,831,56384,995,34181,415,07277,705,52175,313,59476,279,65377,784,68976,715,94677,839,17275,193,64473,954,97212,691,49513,626,2338,211,1926,276,74626,679,88526,842,71423,810,33326,283,96530,779,96729,995,45717,449,48326,482,94127,364,59125,228,277136,686,605
   > Total Current Liabilities 
128,681,336
17,875,239
20,139,813
19,688,297
12,687,458
26,959,122
27,559,007
23,241,556
21,032,863
24,027,571
23,977,233
3,714,156
5,468,044
5,597,901
3,480,465
59,854,776
60,785,919
60,868,765
60,212,252
61,745,846
61,091,273
63,495,456
65,235,175
68,079,699
67,831,662
64,095,905
64,184,112
67,960,363
48,933,853
45,860,622
49,332,981
56,660,973
73,461,940
80,402,237
75,816,526
90,479,059
73,424,235
76,626,103
75,859,547
14,918,333
15,079,443
13,359,471
10,486,449
11,423,664
12,297,700
20,906,207
16,260,463
13,695,602
11,065,998
11,291,827
22,118,809
11,072,872
6,421,865
4,076,977
3,892,299
3,168,504
3,100,878
3,482,065
3,482,0653,100,8783,168,5043,892,2994,076,9776,421,86511,072,87222,118,80911,291,82711,065,99813,695,60216,260,46320,906,20712,297,70011,423,66410,486,44913,359,47115,079,44314,918,33375,859,54776,626,10373,424,23590,479,05975,816,52680,402,23773,461,94056,660,97349,332,98145,860,62248,933,85367,960,36364,184,11264,095,90567,831,66268,079,69965,235,17563,495,45661,091,27361,745,84660,212,25260,868,76560,785,91959,854,7763,480,4655,597,9015,468,0443,714,15623,977,23324,027,57121,032,86323,241,55627,559,00726,959,12212,687,45819,688,29720,139,81317,875,239128,681,336
       Short-term Debt 
124,508,332
16,684,401
18,405,810
18,273,490
11,283,764
25,691,154
25,958,455
21,878,551
19,970,711
22,607,414
22,798,747
2,369,999
3,812,000
3,812,000
1,935,000
46,112,851
46,199,699
46,798,046
46,439,067
44,733,858
44,046,956
49,232,075
51,382,461
50,328,788
49,377,488
46,534,777
47,446,618
48,409,724
29,246,060
27,598,822
31,456,077
41,275,696
52,790,589
45,857,691
42,836,642
51,913,947
42,487,825
41,752,685
50,651,781
8,199,909
6,756,149
5,093,793
5,086,959
5,201,241
5,266,959
8,132,785
8,232,448
7,011,593
5,843,271
5,439,710
5,739,267
6,720,568
1,933,556
709,735
0
0
0
0
0000709,7351,933,5566,720,5685,739,2675,439,7105,843,2717,011,5938,232,4488,132,7855,266,9595,201,2415,086,9595,093,7936,756,1498,199,90950,651,78141,752,68542,487,82551,913,94742,836,64245,857,69152,790,58941,275,69631,456,07727,598,82229,246,06048,409,72447,446,61846,534,77749,377,48850,328,78851,382,46149,232,07544,046,95644,733,85846,439,06746,798,04646,199,69946,112,8511,935,0003,812,0003,812,0002,369,99922,798,74722,607,41419,970,71121,878,55125,958,45525,691,15411,283,76418,273,49018,405,81016,684,401124,508,332
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
54,233,451
51,698,346
65,172,914
22,986,259
20,179,239
296,300
281,600
14,169,786
10,452,200
8,199,909
6,756,149
5,093,793
5,086,959
5,085,589
5,033,966
7,317,920
7,237,638
6,467,144
4,900,000
4,900,000
4,800,000
1,920,568
1,230,000
0
0
0
0
0
000001,230,0001,920,5684,800,0004,900,0004,900,0006,467,1447,237,6387,317,9205,033,9665,085,5895,086,9595,093,7936,756,1498,199,90910,452,20014,169,786281,600296,30020,179,23922,986,25965,172,91451,698,34654,233,451000000000000000000000000000000
       Accounts payable 
790,292
525,523
1,006,526
408,873
562,208
496,462
844,256
659,102
287,399
671,070
602,681
357,755
929,453
972,257
553,134
9,173,941
9,514,225
9,528,747
8,911,787
12,044,593
12,635,009
9,920,548
10,050,678
12,734,963
13,388,229
12,246,120
12,314,118
11,313,426
15,182,382
13,338,297
12,963,508
10,426,278
11,331,251
14,892,384
12,339,652
11,442,774
13,614,515
12,451,846
9,168,454
639,177
645,446
670,178
784,248
837,393
958,886
772,863
708,193
759,971
490,912
1,178,205
1,091,221
438,525
576,277
613,357
503,055
459,279
508,593
695,679
695,679508,593459,279503,055613,357576,277438,5251,091,2211,178,205490,912759,971708,193772,863958,886837,393784,248670,178645,446639,1779,168,45412,451,84613,614,51511,442,77412,339,65214,892,38411,331,25110,426,27812,963,50813,338,29715,182,38211,313,42612,314,11812,246,12013,388,22912,734,96310,050,6789,920,54812,635,00912,044,5938,911,7879,528,7479,514,2259,173,941553,134972,257929,453357,755602,681671,070287,399659,102844,256496,462562,208408,8731,006,526525,523790,292
       Other Current Liabilities 
3,382,712
665,315
727,477
1,005,934
841,486
771,506
756,296
703,903
774,753
749,087
575,805
986,402
726,591
813,644
992,331
4,555,345
5,059,356
4,529,333
4,848,759
4,954,756
4,396,669
4,330,194
3,789,397
5,003,309
5,053,306
5,288,271
4,388,974
8,189,603
4,460,653
4,872,956
4,899,863
4,945,610
9,326,729
19,638,316
20,626,986
27,109,097
17,309,256
22,421,572
16,039,312
6,079,247
7,677,848
7,595,500
4,615,243
5,385,030
6,071,855
12,000,559
7,319,822
5,924,038
4,731,815
4,673,912
15,288,321
3,913,779
3,912,033
2,753,886
-1
0
0
-1
-100-12,753,8863,912,0333,913,77915,288,3214,673,9124,731,8155,924,0387,319,82212,000,5596,071,8555,385,0304,615,2437,595,5007,677,8486,079,24716,039,31222,421,57217,309,25627,109,09720,626,98619,638,3169,326,7294,945,6104,899,8634,872,9564,460,6538,189,6034,388,9745,288,2715,053,3065,003,3093,789,3974,330,1944,396,6694,954,7564,848,7594,529,3335,059,3564,555,345992,331813,644726,591986,402575,805749,087774,753703,903756,296771,506841,4861,005,934727,477665,3153,382,712
   > Long-term Liabilities 
8,005,269
7,353,038
7,224,778
6,794,644
4,762,024
3,036,335
3,220,960
3,042,409
2,777,470
2,815,143
2,702,653
2,562,590
2,743,148
8,028,332
9,211,029
14,100,196
14,407,725
16,970,406
16,503,693
16,038,843
15,188,379
11,818,138
12,470,347
13,335,373
17,163,678
14,735,658
21,557,445
16,391,713
39,526,630
37,225,960
29,673,048
18,020,116
19,337,366
19,558,262
19,601,466
19,628,377
19,738,462
19,404,638
11,394,953
6,524,273
5,258,512
7,348,136
6,680,916
8,718,771
9,523,021
7,557,614
7,431,412
7,742,853
8,543,371
8,260,432
7,187,179
6,726,888
6,606,367
6,496,671
5,765,562
5,818,901
5,911,022
6,272,876
6,272,8765,911,0225,818,9015,765,5626,496,6716,606,3676,726,8887,187,1798,260,4328,543,3717,742,8537,431,4127,557,6149,523,0218,718,7716,680,9167,348,1365,258,5126,524,27311,394,95319,404,63819,738,46219,628,37719,601,46619,558,26219,337,36618,020,11629,673,04837,225,96039,526,63016,391,71321,557,44514,735,65817,163,67813,335,37312,470,34711,818,13815,188,37916,038,84316,503,69316,970,40614,407,72514,100,1969,211,0298,028,3322,743,1482,562,5902,702,6532,815,1432,777,4703,042,4093,220,9603,036,3354,762,0246,794,6447,224,7787,353,0388,005,269
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,742,647
4,143,685
4,127,802
4,308,853
4,405,052
4,643,140
4,707,846
5,072,750
5,751,179
5,823,158
5,921,978
7,683,186
13,476,489
11,640,768
6,895,674
7,597,466
6,955,041
7,190,637
7,248,541
7,394,956
7,503,670
9,372,333
9,364,792
6,475,373
5,209,612
5,788,576
5,121,356
6,702,730
6,872,152
6,121,641
6,346,259
6,647,718
6,749,654
6,197,010
5,655,723
0
0
0
0
0
0
0
00000005,655,7236,197,0106,749,6546,647,7186,346,2596,121,6416,872,1526,702,7305,121,3565,788,5765,209,6126,475,3739,364,7929,372,3337,503,6707,394,9567,248,5417,190,6376,955,0417,597,4666,895,67411,640,76813,476,4897,683,1865,921,9785,823,1585,751,1795,072,7504,707,8464,643,1404,405,0524,308,8534,127,8024,143,6853,742,6470000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,355,839
9,289,121
9,731,149
9,738,999
9,427,347
1,883,632
1,750,705
1,617,778
3,834,850
2,393,333
2,283,667
2,158,333
2,040,833
1,923,333
1,806,214
1,688,333
1,570,833
200,001
0
0
0
0
0
0
0
0
0
0
0000000000200,0011,570,8331,688,3331,806,2141,923,3332,040,8332,158,3332,283,6672,393,3333,834,8501,617,7781,750,7051,883,6329,427,3479,738,9999,731,1499,289,1219,355,839000000000000000000000000000000
> Total Stockholder Equity
43,081,161
34,189,961
34,639,030
56,024,078
56,141,859
56,154,373
55,253,311
57,586,238
56,413,373
56,053,045
55,011,221
62,673,319
52,858,859
42,432,486
42,636,168
54,767,636
53,855,732
61,258,204
60,599,287
55,009,237
54,805,470
55,292,431
54,965,180
53,719,471
79,111,194
78,234,342
79,603,454
76,855,487
70,342,378
69,862,341
72,867,970
70,301,657
71,728,906
66,559,493
62,318,138
52,723,600
50,931,502
42,645,724
48,242,421
64,787,134
64,691,250
57,464,747
54,612,281
51,962,806
52,233,905
54,431,263
57,555,782
49,608,155
52,334,305
52,364,721
52,823,900
74,326,741
82,964,151
70,407,766
71,392,358
74,051,702
73,315,311
73,499,549
73,499,54973,315,31174,051,70271,392,35870,407,76682,964,15174,326,74152,823,90052,364,72152,334,30549,608,15557,555,78254,431,26352,233,90551,962,80654,612,28157,464,74764,691,25064,787,13448,242,42142,645,72450,931,50252,723,60062,318,13866,559,49371,728,90670,301,65772,867,97069,862,34170,342,37876,855,48779,603,45478,234,34279,111,19453,719,47154,965,18055,292,43154,805,47055,009,23760,599,28761,258,20453,855,73254,767,63642,636,16842,432,48652,858,85962,673,31955,011,22156,053,04556,413,37357,586,23855,253,31156,154,37356,141,85956,024,07834,639,03034,189,96143,081,161
   Common Stock
24,463,439
24,463,439
24,463,439
39,463,439
39,463,439
39,463,439
39,463,439
39,463,439
39,463,439
39,463,439
39,463,439
39,463,439
39,463,439
39,463,439
39,463,439
40,105,799
40,105,799
50,105,799
50,105,799
50,116,180
50,116,180
50,116,180
50,149,768
50,149,768
77,649,768
77,649,768
77,649,768
77,649,768
77,649,768
77,649,768
80,530,422
80,530,422
81,493,398
81,516,801
81,527,328
81,573,256
82,028,938
83,209,639
84,267,552
114,267,552
114,267,552
114,267,552
114,267,552
50,899,498
50,899,498
59,284,983
59,284,983
59,286,025
59,291,503
59,291,503
59,291,503
59,291,503
59,291,503
59,291,503
0
0
0
0
000059,291,50359,291,50359,291,50359,291,50359,291,50359,291,50359,286,02559,284,98359,284,98350,899,49850,899,498114,267,552114,267,552114,267,552114,267,55284,267,55283,209,63982,028,93881,573,25681,527,32881,516,80181,493,39880,530,42280,530,42277,649,76877,649,76877,649,76877,649,76877,649,76877,649,76850,149,76850,149,76850,116,18050,116,18050,116,18050,105,79950,105,79940,105,79940,105,79939,463,43939,463,43939,463,43939,463,43939,463,43939,463,43939,463,43939,463,43939,463,43939,463,43939,463,43939,463,43924,463,43924,463,43924,463,439
   Retained Earnings 
-16,859,003
-20,241,241
-19,792,172
-18,890,537
-18,772,756
-18,759,699
-19,663,936
-17,328,372
-18,501,242
-18,861,570
-19,665,269
-12,009,916
-27,333,339
-37,759,712
-37,556,030
-34,923,778
-3,771,865
-5,978,574
-6,637,491
-12,242,373
-12,436,399
-12,138,770
-12,684,306
-13,929,807
-6,752,344
-7,632,076
-6,512,789
-8,878,501
-16,280,491
-16,272,702
-25,646,885
-28,184,961
-19,874,861
-25,106,139
-29,782,035
-39,140,441
-42,480,848
-52,461,627
-49,689,855
-61,337,741
-61,443,520
-68,380,378
-68,488,401
-8,203,477
-5,484,945
-13,814,901
-9,751,073
-18,667,530
-15,932,287
-16,652,550
-16,210,649
5,364,158
14,001,569
1,443,151
2,434,890
4,776,062
4,152,708
4,351,607
4,351,6074,152,7084,776,0622,434,8901,443,15114,001,5695,364,158-16,210,649-16,652,550-15,932,287-18,667,530-9,751,073-13,814,901-5,484,945-8,203,477-68,488,401-68,380,378-61,443,520-61,337,741-49,689,855-52,461,627-42,480,848-39,140,441-29,782,035-25,106,139-19,874,861-28,184,961-25,646,885-16,272,702-16,280,491-8,878,501-6,512,789-7,632,076-6,752,344-13,929,807-12,684,306-12,138,770-12,436,399-12,242,373-6,637,491-5,978,574-3,771,865-34,923,778-37,556,030-37,759,712-27,333,339-12,009,916-19,665,269-18,861,570-18,501,242-17,328,372-19,663,936-18,759,699-18,772,756-18,890,537-19,792,172-20,241,241-16,859,003
   Capital Surplus 0000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
35,476,725
29,967,763
29,967,763
35,451,176
35,451,176
35,450,633
35,453,808
35,451,171
35,451,176
35,451,176
35,213,051
35,219,796
40,728,759
40,728,759
40,728,759
49,585,615
17,521,798
17,130,979
17,130,979
17,135,430
17,125,689
17,315,021
17,499,718
17,499,511
8,213,770
8,216,650
8,466,475
8,084,221
8,973,101
8,485,275
17,984,433
17,956,196
10,110,369
10,148,831
10,572,845
10,290,785
11,383,412
11,897,712
13,664,724
11,857,324
11,867,218
11,577,573
8,833,130
9,266,785
6,819,352
8,961,182
8,021,872
8,989,661
8,975,089
9,725,768
9,743,047
9,671,080
9,671,080
9,673,112
0
0
0
0
00009,673,1129,671,0809,671,0809,743,0479,725,7688,975,0898,989,6618,021,8728,961,1826,819,3529,266,7858,833,13011,577,57311,867,21811,857,32413,664,72411,897,71211,383,41210,290,78510,572,84510,148,83110,110,36917,956,19617,984,4338,485,2758,973,1018,084,2218,466,4758,216,6508,213,77017,499,51117,499,71817,315,02117,125,68917,135,43017,130,97917,130,97917,521,79849,585,61540,728,75940,728,75940,728,75935,219,79635,213,05135,451,17635,451,17635,451,17135,453,80835,450,63335,451,17635,451,17629,967,76329,967,76335,476,725



Balance Sheet

Currency in KRW. All numbers in thousands.




Cash Flow

Currency in KRW. All numbers in thousands.




Income Statement

Currency in KRW. All numbers in thousands.


Latest Income Statement (annual, 2023-03-31)

Gross Profit (+$)
totalRevenue28,819,028
Cost of Revenue-18,994,584
Gross Profit9,824,4449,824,444
 
Operating Income (+$)
Gross Profit9,824,444
Operating Expense-27,366,222
Operating Income1,452,807-17,541,778
 
Operating Expense (+$)
Research Development1,801,325
Selling General Administrative3,008,353
Selling And Marketing Expenses0
Operating Expense27,366,2224,809,679
 
Net Interest Income (+$)
Interest Income1,524,755
Interest Expense-252,282
Other Finance Cost-1,113,933
Net Interest Income2,386,406
 
Pretax Income (+$)
Operating Income1,452,807
Net Interest Income2,386,406
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-12,590,7321,452,807
EBIT - interestExpense = -252,282
-12,423,708
-12,171,426
Interest Expense252,282
Earnings Before Interest and Taxes (EBIT)0-12,338,450
Earnings Before Interest and Taxes (EBITDA)-9,248,325
 
After tax Income (+$)
Income Before Tax-12,590,732
Tax Provision--167,024
Net Income From Continuing Ops-12,423,708-12,423,708
Net Income-12,423,708
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-2,386,406
 

Technical Analysis of Orient
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Orient. The general trend of Orient is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Orient's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of ORIENTBIO Inc..

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 623.00 < 623.00 < 632.00.

The bearish price targets are: 592.00 > 587.00 > 555.00.

Tweet this
ORIENTBIO Inc. Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of ORIENTBIO Inc.. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

ORIENTBIO Inc. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of ORIENTBIO Inc.. The current macd is 4.01133399.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Orient price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Orient. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Orient price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
ORIENTBIO Inc. Daily Moving Average Convergence/Divergence (MACD) ChartORIENTBIO Inc. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of ORIENTBIO Inc.. The current adx is 27.24.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Orient shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
ORIENTBIO Inc. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of ORIENTBIO Inc.. The current sar is 562.73.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
ORIENTBIO Inc. Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of ORIENTBIO Inc.. The current rsi is 62.72. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
ORIENTBIO Inc. Daily Relative Strength Index (RSI) ChartORIENTBIO Inc. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of ORIENTBIO Inc.. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Orient price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
ORIENTBIO Inc. Daily Stochastic Oscillator ChartORIENTBIO Inc. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of ORIENTBIO Inc.. The current cci is 126.61.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
ORIENTBIO Inc. Daily Commodity Channel Index (CCI) ChartORIENTBIO Inc. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of ORIENTBIO Inc.. The current cmo is 33.62.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
ORIENTBIO Inc. Daily Chande Momentum Oscillator (CMO) ChartORIENTBIO Inc. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of ORIENTBIO Inc.. The current willr is -20.37037037.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Orient is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
ORIENTBIO Inc. Daily Williams %R ChartORIENTBIO Inc. Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of ORIENTBIO Inc..

ORIENTBIO Inc. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of ORIENTBIO Inc.. The current atr is 14.43.

ORIENTBIO Inc. Daily Average True Range (ATR) ChartORIENTBIO Inc. Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of ORIENTBIO Inc.. The current obv is 97,694,034.

ORIENTBIO Inc. Daily On-Balance Volume (OBV) ChartORIENTBIO Inc. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of ORIENTBIO Inc.. The current mfi is 72.29.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
ORIENTBIO Inc. Daily Money Flow Index (MFI) ChartORIENTBIO Inc. Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for ORIENTBIO Inc..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-06CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-14STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-15STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-16STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-17STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-23STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-04CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-11CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-09CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-10BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-24SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-16MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-18RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-27RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-29STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

ORIENTBIO Inc. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of ORIENTBIO Inc. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5062.722
Ma 20Greater thanMa 50575.700
Ma 50Greater thanMa 100583.700
Ma 100Greater thanMa 200595.330
OpenGreater thanClose589.000
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Orient with someone you think should read this too:
  • Are you bullish or bearish on Orient? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Orient? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about ORIENTBIO Inc.

I send you an email if I find something interesting about ORIENTBIO Inc..


Comments

How you think about this?

Leave a comment

Stay informed about ORIENTBIO Inc..

Receive notifications about ORIENTBIO Inc. in your mailbox!